EngelA.G., SahashiK., FumagalliG.The immunopathology of acquired myasthenia gravis. Ann NY Acad Sci1981; 377: 158–74.
2.
DrachmanD.B., AdamsR.N., JosifekL.F., PestronkA., StanleyE.S.Antibody-mediated mechanisms of Ach receptor loss in myasthenia gravis: Clinical relevance. Ann NY Acad Sci1981; 377: 175–88.
3.
BarakaA.Anaesthesia and myasthenia gravis. Can J Anaesth1992; 39 (5), 476–86.
4.
HunterJ.M., BellC.F., FlorenceA.M., JonesG.F.Vecuronium in the myasthenic patient. Anaesthesia1985; 40: 848–53.
5.
BarakaA., DajaniA.Atracurium in myasthenics undergoing thymectomy. Anesth Analg1984; 63: 127–30.
6.
GreeneL.F., GhoshM.K., HowardF.M.Transurethral prostatic resection in patients with myasthenia gravis. J Urol1974; 112: 226.
7.
RolbinS.H., LevinsonG., ShniderSM. Anesthetic considerations for myasthenia gravis and pregnancy. Anesth Analg1978; 57: 441.
8.
MillerJ.D., LeeC.Muscle diseases, myasthenia gravis In: Anesthesia and uncommon diseases.Katz, Benumof, Kadis eds., 3rd ed. Philadelphia, London, Tokyo: W. B. Saunders Company1990: 615–621.
9.
YoungH.S.A., ClarkeR.S.J., DundeeJ.W.Intubating conditions with AH 8165 and suxamethonium. Anaesthesia1975; 30: 30–33.
10.
OssermanK., GenkinsG.Studies in myasthenia gravis. Mount Sinai J Med1971; 38: 497–537.
11.
LohL.Neurological and neuromuscular disease. Br J Anaesth1986; 58: 180–200.
12.
FoldesF.F., McNailPCsMyasthenia gravis: A guide for anaesthesiologists. Anesthesiology1962; 23: 837–72.
13.
EisenkraftJ.B., PapatestasA.E., SivaxM.Neuromuscular effects of halogenated agents in patients with myasthenia gravis. Anesthesiology1984; 61 (3A): 307.
14.
RowbottomS.J.Isoflurane for thymectomy in myasthenia gravis. Anaesth Intens Care1989; 17: 444–447.
15.
LeventhalS.R., OrkinF.K., HirschR.A.Prediction of the need for postoperative ventilation in myasthenia gravis. Anesthesiology1980; 53: 26–30.
16.
ReadfernN., McGuillanN.J., ConacherI.D., PearsonD.T.Anaesthesia for trans-sternal thymectomy in myasthenia gravis. Ann R Coll Surg Engl1987; 69: 289–292.
